Cases 31 - 40 of 72
Merck Sharp & Dohme Corp. v. Aurobindo Pharma, Ltd. et al
as 1:2020cv01099
Defendant:
Aurobindo Pharma, Ltd. and Aurobindo Pharma USA Inc.
Plaintiff:
Merck Sharp & Dohme Corp.
Cause Of Action: 35 U.S.C. § 271
Cephalon, Inc. v. Aurobindo Pharma, Ltd. et al
as 1:2020cv00962
Defendant:
Aurobindo Pharma USA, Inc., Aurobindo Pharma, Ltd. and Eugia Pharma Specialities Ltd.
Plaintiff:
Cephalon, Inc.
Cause Of Action: 35 U.S.C. § 271
Teva Pharmaceuticals International GmbH et al v. Aurobindo Pharma, Ltd. et al
as 1:2020cv00632
Plaintiff:
Teva Pharmaceuticals International GmbH, Eagle Pharmaceuticals, Inc. and Cephalon, Inc.
Defendant:
Aurobindo Pharma, Ltd., Aurobindo Pharma USA, Inc. and Eugia Pharma Specialities Ltd.
Cause Of Action: 35 U.S.C. § 271
In re: Palbociclib Patent Litigation
as 1:2019md02912
Not Classified By Court:
Aizant Drug Research Solutions Pvt. Ltd., Hetero USA Inc., Teva Pharmaceuticals USA, Inc. and others
In Re:
In re: Palbociclib Patent Litigation
Cause Of Action: 35 U.S.C. § 271
Taiho Pharmaceutical Co., Ltd. et al v. Eugia Pharma Specialities Ltd. et al
as 1:2019cv02309
Plaintiff:
Taiho Oncology, Inc. and Taiho Pharmaceutical Co., Ltd.
Defendant:
Aurobindo Pharma U.S.A., Inc., Eugia Pharma Specialities Ltd. and Aurobindo Pharma Ltd.
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation v. Alkem Laboratories Ltd. et al
as 1:2019cv01979
Defendant:
Teva Pharmaceuticals USA, Inc., Aurobindo Pharma USA Inc., Lupin Inc. and others
Plaintiff:
Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Aurobindo Pharma Ltd. et al
as 1:2019cv01862
Defendant:
Aurobindo Pharma USA, Inc. and Aurobindo Pharma Ltd.
Plaintiff:
Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc. and Boehringer Ingelheim International GmbH
Cause Of Action: 35 U.S.C. § 271
Otsuka Pharmaceutical Co., Ltd. et al v. Aurobindo Pharma Ltd. et al
as 1:2019cv01965
Defendant:
Aurobindo Pharma USA Inc. and Aurobindo Pharma Ltd.
Plaintiff:
Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S
Cause Of Action: 35 U.S.C. § 271
Pfizer Inc. et al. v. Aurobindo Pharma, Ltd. et al.
as 1:2019cv00748
Defendant:
Aurobindo Pharma USA, Inc., Aurobindo Pharma, Ltd. and Eugia Pharma Specialties Ltd.
Plaintiff:
Pfizer Manufacturing Holdings LLC, Pfizer PFE Ireland Pharmaceuticals Holding 1 B.V., Pfizer Inc. and others
Cause Of Action: 35 U.S.C. § 271
Bristol-Myers Squibb Company et al v. Aurobindo Pharma USA Inc.
as 1:2017cv00374
Defendant:
Aurobindo Pharma USA Inc., Indoco Remedies Ltd., Dr. Reddy's Laboratories Inc. and others
Plaintiff:
Bristol-Myers Squibb Company and Pfizer Inc.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
